Impact News +++ Directors’ Dealings News: Heidelberg Materials AG (EQS) +++ HEIDELBERG MATERIALS Aktie +3,54%

COSMO PHARMA Aktie

>COSMO PHARMA Aktienkurs

61 EUR +0.8% (Tradegate)

Ask: 61.5 EUR / 81 Stück

Bid: 61 EUR / 81 Stück

Tagesumsatz: 6 Stück

Realtime Kurs von 8 bis 22 Uhr!

COSMO PHARMA Aktie über LYNX handeln

Intraday

1 Jahr

>COSMO PHARMA Performance

1 Woche: -3,6%

1 Monat: +0,4%

3 Monate: +2,1%

6 Monate: -8,0%

1 Jahr: -18,0%

laufendes Jahr: -12,0%

>COSMO PHARMA Aktie

Name:

COSMO PHARMACEUTICALS

Land:

Niederlande

Sektor:

Gesundheit

ISIN/ Wkn:

NL0011832936 / A2AJ68

Symbol/ Ticker:

C43 (Frankfurt)

Kürzel:

FRA:C43, ETR:C43, C43:GR

Index:

Webseite:

https://www.cosmopharma.c..

Marktkapitalisierung:

1010 Mio. EUR

Umsatz:

266.79 Mio. EUR

EBITDA:

160.47 Mio. EUR

Gewinn je Aktie:

8.11 EUR

Schulden:

2.2 Mio. EUR

Liquide Mittel:

142.96 Mio. EUR

Umsatz-/ Gewinnwachstum:

165.8% / -

KGV/ KGV lG:

7.7 / 13.68

KUV/ KBV/ PEG:

3.85 / 2.01 / -

Gewinnm./ Eigenkapitalr.:

49.94% / 29.31%

Dividende je Aktie:

4.04 EUR

Dividendenrendite/ -schätzung:

6.5% / 3.28%

Div. Historie:

04.06.25 - 2.04295€
10.07.24 - 1.99668€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

COSMO PHARMA, COSMO PHARMACEUTICALS, COSMO PHARMACEUTICAL

Letzte Datenerhebung:

24.06.25

>COSMO PHARMA Eigentümer

Aktien: 16.02 Mio. St.

f.h. Aktien: 8.52 Mio. St.

Insider Eigner: 47.29%

Instit. Eigner: 13.23%

Leerverk. Aktien: -

>COSMO PHARMA Peer Group

IMMATICS

INFLARX

LAVA THERAPEUTICS

NEWAMSTERDAM

ONWARD MEDICAL

PHARMING

PHARVARIS

PROQR

TME PHARMA

VIVORYON

>COSMO PHARMA Chart & Kurs - Tradegate

>COSMO PHARMA News

24.06.25 - 07:24	Cosmo Pharmaceuticals N.V.: Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius with Apple Vision Pro at Rush University Medical Center (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. ("Cosmo") today announced that in July 2025, it will initiate their first usability study of a medical device softwar......

03.06.25 - 23:51	XFRA: DIVIDEND/INTEREST INFORMATION - 04.06.2025 - EQUBF_01 (XETRA)
	Das Instrument C43 NL0011832936 COSMO PHARMACEUT. EO-,26 EQUITY wird ex Dividende/Zinsen gehandelt am 04.06.2025 The instrument C43 NL0011832936 COSMO PHARMACEUT. EO-,26 EQUITY has its ex-dividend/interest day on 04.06.2025...

02.06.25 - 23:42	XFRA: DIVIDEND/INTEREST INFORMATION - 04.06.2025 - EQUBF_01 (XETRA)
	Das Instrument C43 NL0011832936 COSMO PHARMACEUT. EO-,26 EQUITY wird cum Dividende/Zinsen gehandelt am 03.06.2025 und ex Dividende/Zinsen am 04.06.2025 The instrument C43 NL0011832936 COSMO PHARMACEUT. EO-,26 EQUITY has its pre-dividend/interest day on 03.06.2025 and its ex-dividend/interest day on 04.06.2025...

30.05.25 - 15:18	Cosmo Pharmaceuticals N.V.: Voting Results of Cosmo′s 2025 AGM (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - May 30, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") announced that its shareholders approved all voting items at today's Ordinary Annual ......

05.05.25 - 07:06	Cosmo Pharmaceuticals N.V.: Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Week(R) 2025 (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - May 5, 2025) - Cosmo is attending this year's Digestive Disease Week® (DDW), held in San Diego, California from May 3-6, where its leadership team is advancing a......

02.05.25 - 07:18	Cosmo Pharmaceuticals N.V.: Cosmo Announces EU MDR Certification for Endovision′s Cerebro, expanding its real-time AI ecosystem (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - May 2, 2025) - Cosmo is excited to announce that Endovision Limited, a leading innovator in endoscopic imaging solutions, has received EU MDR certification[1] fo......

30.04.25 - 17:03	XETR: Deletion of Instruments from XETRA - 30.04.2025 (XETRA)
	The following instruments on XETRA do have their last trading day on 30.04.2025. Die folgenden Instrumenteauf XETRA haben ihren letzten Handelstag am 30.04.2025. ISIN Name NL0011832936 Cosmo Pharmaceuticals N.V. US35952H7008 Fuelcell Energy Inc. US7185461040 Phillips 66 US4278661081 The Hershey Co....

29.04.25 - 15:24	Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals Confirms Financial Guidance Following CHMP Opinion on Winlevi(R) (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Following the recent CHMP opinion regarding the marketing authorization application for Winlevi® (clascoterone cream 1%) in Europe, Cosmo Pharm......

29.04.25 - 07:30	Cosmo Pharmaceuticals N.V.: Cosmo Receives Negative CHMP Opinion on Winlevi(R) (clascoterone Cream 1%) in Europe and Will Appeal the Decision (Newsfile)
	Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) announces that the Committee for Medicinal Products for Human......

29.04.25 - 07:18	Cosmo Pharmaceuticals N.V.: Cosmo Publishes Agenda of AGM 2025 (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo" or the "Company") today announced the convening of its Annual General Meeting 2025 t......

01.04.25 - 08:18	Cosmo Pharmaceuticals ernennt neuen Chief Legal Counsel (Cash)
	Biopharma - Der Pharmakonzern Cosmo Pharmaceuticals hat Federico Sommariva zum neuen Chief Legal Counsel ernannt....

01.04.25 - 07:18	Cosmo Pharmaceuticals N.V.: Cosmo Appoints Federico Sommariva as Chief Legal Counsel (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - April 1, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") today announced the appointment of Federico Sommariva ad Chief Legal Counsel. Federi......

21.03.25 - 16:57	Cosmo Pharmaceuticals reports FY results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.03.25 - 07:18	Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals publishes Annual Report 2024 (Newsfile)
	Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - March 21, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") has published today its Annual Report fo......

06.03.25 - 22:57	Cosmo Pharmaceuticals N.V. reports FY results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.03.25 - 08:12	Cosmo wächst dank Schlüsselprodukten 2024 weiter (Moneycab)
	Das Spezialitätenpharma-Unternehmen Cosmo hat 2024 einen Gewinnsprung verzeichnet. Der Umsatz hat sich derweil nahezu verdreifacht....

06.03.25 - 07:06	Cosmo Pharmaceuticals N.V.: Cosmo Pharmaceuticals Delivers Record 2024 Results - Completes Phase III Enrollment for Androgenetic Alopecia in Males - Proposes Increased Dividend of 2.05 per share - Reinforcing Shareholder Value and Growth Momentum int (Newsfile)
	Ad hoc announcement pursuant to Art. 53 LR FY 2024 Revenue of €266.8 million (unaudited) reaching upper end of guidance FY 2024 Operating Profit (unaudited) of €148.9 million, exceeding guidance, ......

12.02.25 - 07:12	Cosmo Pharmaceuticals N.V.: Cosmo to Host Investor Day on April 9, 2025 (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - February 12, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") is pleased to announce that it will host an Investor Day on Wednesday, April 9, ......

11.02.25 - 07:54	Cosmo ernennt Andrea Cherubini zum Chief AI Officer (Cash)
	Biopharmaunternehmen - Das Biopharmaunternehmen hat Andrea Cherubini mit sofortiger Wirkung zum Chief AI Officer ernannt....

11.02.25 - 07:06	Cosmo Pharmaceuticals N.V.: Cosmo Appoints Andrea Cherubini as Chief AI Officer to Drive AI Expansion Across Portfolio (Newsfile)
	Dublin, Ireland--(Newsfile Corp. - February 11, 2025) - Planet Friendly Technologies, Inc.Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) ("Cosmo") today announced the appointment of Andrea Cher......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram